Tendering emerged as the most effective strategy for reducing costs and increasing biosimilar uptake in the retail setting, ...

Alvotech acquires Xbrane’s R&D operations and the biosimilar candidate XB003. Xbrane retains some pre-clinical development programs, that it intends to commercialize, and will continue operating as a ...

“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

The inquiry is the latest effort by the European Commission and European countries to scrutinize potential antitrust behavior ...

Celltrion and Formycon with Fresenius Kabi launched their respective ustekinumab biosimilars (Steqeyma and Otulfi), joining 4 ...

LEHI, Utah--(BUSINESS WIRE)--Xevant, a leader in pharmacy benefits automation, today announces the launch of its all-new Biosimilar Dashboard, a real-time analytics tool designed to streamline ...

Sandoz reported a 9% growth in net sales of generics and biosimilars to third parties for 2024, marking a strong first financial year as an independent company. After completing its spin-off from ...

For Europe, it is still too early to model,” Sandoz CEO Richard Saynor said in a statement to Pharmaceutical Technology. Sandoz pointed to the uptake of its Humira biosimilar Hyrimoz in the US ...

Companies must reveal all relevant and material information in their financial statements. For example, if there were significant write-downs, a breakdown of how depreciation was calculated should ...

--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, independent developer of high-quality biosimilars ... forward-looking statements that are subject ...

The Associated Press, Bloomberg News and Reuters on Wednesday issued this joint statement: The three permanent wires in the White House pool, The Associated Press, Bloomberg News and Reuters, have ...